Novocure Ltd expected to post a loss of 52 cents a share - Earnings Preview

NovoCure

24/10/2023 19:36

* Novocure Ltd  NVCR.OQ   NVCR.O  is expected to show a fall
in
quarterly revenue when it reports  results 
    * The Saint Helier Jersey-based   company is expected to
report  a
1.7% decrease in revenue to $128.762 million from $131 million a
year ago, according to the mean estimate from 6 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Novocure Ltd is for
a
loss of 52 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Novocure
Ltd is
$35​, above​ its last closing price of $14.07. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2023  -0.49       -0.50      -0.54     Missed  -7.9
 Mar. 31 2023  -0.31       -0.32      -0.50     Missed  -54.5
 Dec. 31 2022  -0.31       -0.30      -0.36     Missed  -18​
 Sep. 30 2022  -0.26       -0.26      -0.25     Beat    4.4
 ​​Jun.        -0.16       -0.14      -0.23     Missed  -58.6
 30 2022                                                
 Mar. 31 2022  -0.18       -0.18      -0.04     Beat    77.8​
 Dec. 31 2021  -0.09       -0.10      -0.25     Missed  -146.5
 Sep. 30 2021  -0.07       -0.07      -0.13     Missed  -76.3
 This summary was machine generated October 24 at 18:36 GMT.  All
figures in US dollars  unless otherwise stated